Clinical Trial Update: 150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial [Phase 3]

View source ↗

Summary

The OPTIMAL-DOSE Phase 3 trial compares 150 IU versus 225 IU of follicle-stimulating hormone (FSH) in normal responders undergoing fertility treatment and is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• follicle-stimulating hormone (follicle-stimulating hormone)

Snippet

Sponsor: American Hospital 2 Kosovo | Conditions: Infertility, Female | Phase 3 | Status: NOT_YET_RECRUITING